June 21, 2025 06:00 AM EDT
Weekly

FDA un­veils new pi­lot pro­gram; Sage finds a buy­er; Eli Lil­ly to ac­quire Verve; and more

Max Gelman

Senior Editor

Nicole DeFeudis

Editor

Wel­come back to an­oth­er edi­tion of End­points Week­ly, and hap­py start to the sum­mer! The North Pole reached its max­i­mum tilt to­ward the sun at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA's top cell and gene ther­a­py lead­ers ex­it agency in on­go­ing CBER changes

A puz­zling up­date from No­vo Nordisk and new da­ta from Roche at #ADA25

In­side the FDA’s ‘lis­ten­ing’ tour: Of­fi­cials agree US lags be­hind Chi­na on drug de­vel­op­ment

Ver­tex's di­a­betes cell ther­a­py al­lows 10 pa­tients to come off in­sulin

Af­ter a qui­et year, Xaira un­wraps some of its AI re­search, eye­ing a vir­tu­al cell

sponsored

This com­pa­ny has spent a decade in­no­vat­ing NGS-based com­pan­ion di­ag­nos­tics world­wide–what’s next?

A service from the Financial Times